Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

Journal of Hepatology

Volumn 58, Issue 6, 2013, Pages 1104-1112

  Berenguer, Juan ^a,b   Alvarez Pellicer, Julio ^c   Carrero, Ana ^a,b   Von Wichmann, Miguel A ^d   López Aldeguer, José ^e   Mallolas, Josep ^f   Galindo, María J ^g   Van Den Eynde, Eva ^h   Téllez, María J ⁱ   Quereda, Carmen ^j   Tural, Cristina ^k   Sanz, José ^l   Barros, Carlos ^m   Santos, Ignacio ⁿ   Pulido, Federico ^o   Guardiola, Josep M ^p   Ortega, Enrique ^q   Rubio, Rafael ^r   Jusdado, Juan J ^s   Montes, María L ^c,s   Gaspar, Gabriel ^t   Barquilla, Elena ^u   Bellón, José M ^a,b   González García, Juan ^c   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^m HOSPITAL DE MÓSTOLES   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^o HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^p HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^q HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^r HOSPITAL SEVERO OCHOA   (Spain)

^s HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^t HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^u Fundacion SEIMC GESIDA   (Spain)

more..

Author keywords

Follow up studies; Hepatitis C chronic complications drug therapy; HIV Infections complications drug therapy; Interferons administration and dosage therapeutic use; Treatment outcome

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; ALANINE AMINOTRANSFERASE; INTERFERON;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; DRUG EFFECT; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; RELAPSE; SPAIN; TREATMENT RESPONSE; VIRUS LOAD; VIRUS TRANSMISSION; BLOOD; COHORT ANALYSIS; COINFECTION; HEPATITIS C, CHRONIC; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; COHORT STUDIES; COINFECTION; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERONS; LIVER; MALE; PROPORTIONAL HAZARDS MODELS; RIBAVIRIN;

EID: 84877922571     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.01.042     Document Type: Article

References (32)

1. C.S. Graham, L.R. Baden, E. Yu, J.M. Mrus, J. Carnie, and T. Heeren Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis Clin Infect Dis 33 2001 562 569
2. R. Weber, C.A. Sabin, N. Friis-Moller, P. Reiss, W.M. El-Sadr, and O. Kirk Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study Arch Intern Med 166 2006 1632 1641
3. M.G. Swain, M.Y. Lai, M.L. Shiffman, W.G. Cooksley, S. Zeuzem, and D.T. Dieterich A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin Gastroenterology 139 2010 1593 1601
4. C. Camma, M. Giunta, P. Andreone, and A. Craxi Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach J Hepatol 34 2001 593 602
5. T. Poynard, J. McHutchison, M. Manns, C. Trepo, K. Lindsay, and Z. Goodman Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
6. C. Camma, D. Di Bona, F. Schepis, E.J. Heathcote, S. Zeuzem, and P.J. Pockros Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data Hepatology 39 2004 333 342
7. S. Pol, F. Carnot, B. Nalpas, J.L. Lagneau, H. Fontaine, and J. Serpaggi Reversibility of hepatitis C virus-related cirrhosis Hum Pathol 35 2004 107 112
8. V. Mallet, H. Gilgenkrantz, J. Serpaggi, V. Verkarre, A. Vallet-Pichard, and H. Fontaine Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C Ann Intern Med 149 2008 399 403
9. B.J. Veldt, E.J. Heathcote, H. Wedemeyer, J. Reichen, W.P. Hofmann, and S. Zeuzem Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis Ann Intern Med 147 2007 677 684
10. A. Lawson, S. Hagan, K. Rye, N. Taguri, S. Ratib, and A.M. Zaitoun The natural history of hepatitis C with severe hepatic fibrosis J Hepatol 47 2007 37 45
11. S. Bruno, T. Stroffolini, M. Colombo, S. Bollani, L. Benvegnu, and G. Mazzella Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study Hepatology 45 2007 579 587
12. C.M. Fernandez-Rodriguez, S. Alonso, S.M. Martinez, X. Forns, J.M. Sanchez-Tapias, and D. Rincon Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response Am J Gastroenterol 105 2010 2164 2172 quiz 2173
13. A.C. Cardoso, R. Moucari, C. Figueiredo-Mendes, M.P. Ripault, N. Giuily, and C. Castelnau Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis J Hepatol 52 2010 652 657
14. J. Berenguer, J. Alvarez-Pellicer, P.M. Martin, J. Lopez-Aldeguer, M.A. Von-Wichmann, and C. Quereda Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients co-infected with human immunodeficiency virus and hepatitis C virus Hepatology 50 2009 407 413
15. J. Berenguer, E. Rodriguez, P. Miralles, M.A. Von Wichmann, J. Lopez-Aldeguer, and J. Mallolas Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients co-infected with human immunodeficiency virus and hepatitis C virus Clin Infect Dis 55 2012 728 736
16. J.G. McHutchison, E.J. Lawitz, M.L. Shiffman, A.J. Muir, G.W. Galler, and J. McCone Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 2009 580 593
17. M.G. Ghany, D.B. Strader, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
18. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-Garcia, and A. Lazzarin Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
19. J. Berenguer, J. Gonzalez-Garcia, J. Lopez-Aldeguer, M.A. Von-Wichmann, C. Quereda, and A. Hernando Pegylated interferon a2a plus ribavirin versus pegylated interferon a2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients J Antimicrob Chemother 63 2009 1256 1263
20. E. Van den Eynde, J.M. Tiraboschi, C. Tural, R. Sola, J.A. Mira, and D. Podzamczer Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV co-infected patients AIDS 24 2010 975 982
21. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group Hepatology 20 1994 15 20
22. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
23. S. Moreno, J. Garcia-Samaniego, A. Moreno, E. Ortega, J.A. Pineda, and J. del Romero Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection J Viral Hepat 16 2009 249 258
24. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
25. M.L. Shiffman, M. Diago, A. Tran, P. Pockros, R. Reindollar, and D. Prati Chronic hepatitis C in patients with persistently normal alanine transaminase levels Clin Gastroenterol Hepatol 4 2006 645 652
26. E. Lissen, N. Clumeck, R. Sola, M. Mendes-Correa, J. Montaner, and M. Nelson Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection AIDS 20 2006 2175 2181
27. J. Macias, J. Berenguer, M.A. Japon, J.A. Giron, A. Rivero, and L.F. Lopez-Cortes Fast fibrosis progression between repeated liver biopsies in patients co-infected with human immunodeficiency virus/hepatitis C virus Hepatology 50 2009 1056 1063
28. M. Potter, A. Odueyungbo, H. Yang, S. Saeed, and M.B. Klein Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy AIDS 24 2010 1857 1865
29. A. Kovacs, L. Al-Harthi, S. Christensen, W. Mack, M. Cohen, and A. Landay CD8(+) T cell activation in women co-infected with human immunodeficiency virus type 1 and hepatitis C virus J Infect Dis 197 2008 1402 1407
30. S.G. Deeks HIV infection, inflammation, immunosenescence, and aging Annu Rev Med 62 2011 141 155
31. I.F. de Castro, D. Micheloud, J. Berenguer, M. Guzman-Fulgencio, P. Catalan, and P. Miralles Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus co-infected patients AIDS 24 2010 2059 2067
32. S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, and L. Tiret Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342